Health & Wellness
InvVax
We use a new genetics platform to develop better vaccines for flu, COVID-19, etc
Pasadena,
CA
Investment type:
Equity
(Convertible Note)
Target raise:
$50,000
- $1,235,000
Minimum investment:
$100
$100
End date:
Jan 16, 2024
Jan 16, 2024
ended
Share
Highlights
- Huge global market for these vaccines: Universal flu – $22B; COVID-19 – $5B
- Chance to make an enormous societal impact
- Patented durable and universal flu vaccine
- Major smashes: Moderna, BioNTech, Novavax: Invest in the next one!